MAZE
Maze Therapeutics, Inc.Company with tickers: MAZE
Market Cap
$1.57B
Shares Outstanding
55,345,261
CIK
1842295
CUSIP
578784100
Investor Relations
Investor relations
Earnings calls and other investor events (conferences, investor days) grouped as single events — the transcript and audio, plus, for earnings calls, the 8-K earnings release and the quarter's 10-Q or 10-K. Each badge shows which artefacts have landed.
| Period | Call date | Event | Artefacts | Open |
|---|---|---|---|---|
| Conference | 2026-06-03 | 2026 Jefferies Global Healthcare Conference in New York |
Audio
Transcript
Slides
|
|
| Conference | 2026-06-10 | Goldman Sachs 47th Annual Global Healthcare Conference 2026 |
Audio
Transcript
Slides
|
|
| FY2026 Q1 | 2026-05-12 | Maze Therapeutics, Inc. Q1 FY2026 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2025 Q4 | 2026-03-25 | Maze Therapeutics, Inc. Q4 FY2025 Earnings Call |
Audio
Transcript
Slides
8-K10-K
|
|
| FY2025 Q3 | 2025-11-06 | Maze Therapeutics, Inc. Q3 FY2025 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2025 Q2 | 2025-08-12 | Maze Therapeutics, Inc. Q2 FY2025 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2025 Q1 | 2025-05-14 | Maze Therapeutics, Inc. Q1 FY2025 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2024 Q4 | 2025-03-31 | Maze Therapeutics, Inc. Q4 FY2024 Earnings Call |
Audio
Transcript
Slides
8-K10-K
|
Showing 1–8 of 8 earnings calls